Investors & Media

Ionis strengthens leadership team with appointments of Joseph Baroldi as chief business officer and Eric Bastings, M.D., as vice president, development strategy

CARLSBAD, Calif. , Jan. 19, 2022 /PRNewswire/ —  Ionis Pharmaceuticals, Inc.  (Nasdaq: IONS) today announced two appointments that strengthen its leadership team and further position it to become a leading, fully integrated biotechnology company. Joseph T.

Read more
You are now leaving to visit